Diagnamed Holdings Corp.
DMED
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 56.90K | 96.70K | 57.30K | 90.90K | 98.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.10K | 84.90K | 114.20K | 188.00K | 108.60K |
| Operating Income | -72.10K | -84.90K | -114.20K | -188.00K | -108.60K |
| Income Before Tax | -95.70K | -142.00K | -161.20K | -93.90K | 29.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -95.70K | -142.00K | -161.20K | -93.90K | 29.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -95.70K | -142.00K | -161.20K | -93.90K | 29.30K |
| EBIT | -72.10K | -84.90K | -114.20K | -188.00K | -108.60K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 80.76M | 80.05M | 80.05M | 80.05M | 80.05M |
| Average Diluted Shares Outstanding | 80.76M | 80.05M | 80.05M | 80.05M | 80.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
